GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
Article Title: GSK, AnaptysBio Enter Legal Battle Over Decade-Old Jemperli Licensing Deal Publication Date: November 21, 2025 In an ongoing industry dispute, healthcare giant GlaxoSmithKline’s (GSK) subsidiary Tesaro and biotech firm AnaptysBio have found themselves embroiled in a legal battle…